Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Podcast | Sexual health in older age

Dr Holly Thomas helps us unpack the needlessly taboo subject of sex and sexual health in women of older age.

Listen now
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in:

Open Access 16-10-2023 | Ehlers-Danlos Syndrome | Review

A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice

Authors: Estée C.H. Feldman, Kendra J. Homan, Sara E. Williams, Tracy V. Ting, Kenneth R. Goldschneider, Susmita Kashikar-Zuck

Published in: Pediatric Rheumatology | Issue 1/2023

Login to get access

Abstract

Background

Hypermobile Ehlers-Danlos syndrome (hEDS) is characterized by joint and skin laxity, and often accompanied by chronic pain, dysautonomia, increased distress and, functional limitations. The journey to accurate diagnosis is often prolonged due to unclear etiology of symptoms. This manuscript is a narrative review of the literature on illness uncertainty (IU) in hEDS, highlighting the unique facets of IU in this population, as compared to the broader chronic pain population (given symptom overlap between these two disease groups), that warrant additional investigation. Additionally, we considered the unique challenges associated with IU in the context of the developmental nuances of pediatric populations. Specifically, we aimed to (1) map the extant literature of the IU experience in chronic pain conditions broadly including the pediatric and adult research to identify key concepts related to IU and incorporate potential developmental considerations in IU; (2) delineate and describe the IU experience specifically in patients with hEDS, with the goal of identifying gaps in the literature based on aspects of presentation in hEDS that do and do not differ from the broader chronic pain population; and (3) elucidate the potential areas of adverse impact of IU in both general chronic pain populations, and those with hEDS specifically, to provide actionable areas for future research and clinical care of individuals with hEDS. Results of this review indicate that IU has been well-studied in chronic pain generally, but inadequately evaluated in hEDS specifically. Specific features of hEDS (complexity of the disorder, involvement of multiple bodily systems, contribution of organic pathology) may uniquely contribute to IU in this population. This review suggests that ambiguities surrounding the diagnosis of hEDS, symptom course, and treatment recommendations, along with misdiagnosis, perceived dismissal of symptoms, or attribution of symptoms to mental health concerns might increase risk for IU and related distress in patients.

Conclusion

Findings from the present review suggest that distinct features of hEDS yield a set of driving factors for IU that may be somewhat different than those faced by patients with chronic pain or other medical conditions. The development of a validated measure of IU to appropriately assess this construct in patients with hEDS is a research priority. In the clinical setting, providers should be attentive to the potentially aversive diagnostic and treatment experiences reported by patients and attempt to provide clear explanations based on the extant knowledge of hEDS, and implement best-practice recommendations for multidisciplinary treatment.
Literature
1.
Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998;77(1):31–7.PubMed
2.
Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, et al. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet C Semin Med Genet. 2017;175(1):48–69.PubMed
3.
Voermans NC, Knoop H, Bleijenberg G, van Engelen BG. Pain in Ehlers-Danlos syndrome is common, severe, and associated with functional impairment. J Pain Symptom Manage. 2010;40(3):370–8.PubMed
4.
Brady AF, Demirdas S, Fournel-Gigleux S, Ghali N, Giunta C, Kapferer-Seebacher I, et al. The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet. 2017;175(1):70–115.PubMed
5.
Grahame R. Hypermobility: an important but often neglected area within rheumatology. Nat Clin Pract Rheumatol. 2008;4(10):522–4.PubMed
6.
Castori M, Morlino S, Celletti C, Celli M, Morrone A, Colombi M, et al. Management of pain and fatigue in the joint hypermobility syndrome (aka Ehlers–Danlos syndrome, hypermobility type): principles and proposal for a multidisciplinary approach. Am J Med Genet Part A. 2012;158(8):2055–70.
7.
Adib N, Davies K, Grahame R, Woo P, Murray K. Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Rheumatology. 2005;44(6):744–50.PubMed
8.
Voermans NC, Knoop H. Both pain and fatigue are important possible determinants of disability in patients with the Ehlers-Danlos syndrome hypermobility type. Disabil Rehabil. 2011;33(8):706–7.PubMed
9.
Williams SE, Tran ST, Lynch-Jordan A, Goldschneider KR, Ting TV, Kashikar‐Zuck S, et al. Healthcare utilization among youth with Ehlers–Danlos syndrome hypermobile type. Am J Med Genet Part A. 2022;188(4):1109–17.PubMed
10.
Hamonet CSP, Bezire P, Ducret L, Brissot R. Cognitive and psychopathological aspects of Ehlers-Danlos syndrome - experience in a specialized medical consultation. Res Adv Brain Disorders Therapy 2018;104.
11.
Anderson LK, Lane KR. The diagnostic journey in adults with hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders. J Am Association Nurse Practitioners. 2022;34(4):639–48.
12.
Wright LJ, Afari N, Zautra A. The Illness uncertainty concept: a review. Curr Pain Headache Rep. 2009;13:133–8.
13.
Reich JW, Johnson LM, Zautra AJ, Davis MC. Uncertainty of Illness relationships with mental health and coping processes in fibromyalgia patients. J Behav Med. 2006;29(4):307–16.PubMed
14.
Johnson LM, Zautra AJ, Davis MC. The role of Illness uncertainty on coping with fibromyalgia symptoms. Health Psychol. 2006;25(6):696–703.PubMedPubMedCentral
15.
Braden CJ. A test of the self-help model: learned response to chronic Illness experience. Nurs Res. 1990;39(1):42–7.PubMed
16.
Landis B. Uncertainty, spiritual well-being, and psychosocial adjustment to chronic Illness. Issues Ment Health Nurs. 1996;17(3):217–31.PubMed
17.
Christman NJ. Uncertainty and adjustment during radiotherapy. Nurs Res. 1990;39(1):17–20.PubMed
18.
Mishel MH, Hostetter T, King B, Graham V. Predictors of psychosocial adjustment in patients newly diagnosed with gynecological cancer. LWW; 1984. pp. 291–300.
19.
MISHEL MH, SORENSON DS. Uncertainty in gynecological cancer: a test of the mediating functions of mastery and coping. Nurs Res. 1991;40(3):167–71.PubMed
20.
Mullins LL, Chaney JM, Hartman VL, Albin K, Miles B, Roberson S. Cognitive and affective features of postpolio syndrome: Illness uncertainty, attributional style, and adaptation. Int J Rehabilitation Health. 1995;1:211–22.
21.
Sanders-Dewey NE, Mullins LL, Chaney JM. Coping style, perceived uncertainty in Illness, and distress in individuals with Parkinson’s Disease and their caregivers. Rehabil Psychol. 2001;46(4):363.
22.
Mullins LL, Cote MP, Fuemmeler BF, Jean VM, Beatty WW, Paul RH. Illness intrusiveness, uncertainty, and distress in individuals with multiple sclerosis. Rehabil Psychol. 2001;46(2):139.
23.
Wineman NM, Schwetz KM, Goodkin DE, Rudick RA. Relationships among Illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trial. Appl Nurs Res. 1996;9(2):53–60.PubMed
24.
Mast ME. Adult uncertainty in illness: A critical review of research. Scholarly inquiry for nursing practice. 1995;9:3-.
25.
McCormick KM. A concept analysis of uncertainty in Illness. J Nurs Scholarsh. 2002;34(2):127–31.PubMed
26.
Mishel MH. The measurement of uncertainty in Illness. Nurs Res. 1981;30(5):258–63.PubMed
27.
Heidlebaugh AR. Illness identity and psychological adaptation in individuals with hypermobile ehlers danlos syndrome or hypermobility spectrum disorder. Johns Hopkins University; 2020.
28.
Bennett SE, Walsh N, Moss T, Palmer S. Understanding the psychosocial impact of joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type: a qualitative interview study. Disabil Rehabil. 2021;43(6):795–804.PubMed
29.
Green BN, Johnson CD, Adams A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006;5(3):101–17.PubMedPubMedCentral
30.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
31.
Tanna V, Heathcote LC, Heirich MS, Rush G, Neville A, Noel M et al. Something else going on? Diagnostic uncertainty in children with Chronic Pain and their parents. Child (Basel). 2020;7(10).
32.
Neville A, Jordan A, Beveridge JK, Pincus T, Noel M. Diagnostic uncertainty in Youth with Chronic Pain and their parents. J Pain. 2019;20(9):1080–90.PubMed
33.
Shayer M, Küchemann D, Wylam H. The distribution of piagetian stages of thinking in British middle and secondary school children. Br J Educ Psychol. 1976;46(2):164–73.
34.
Becker WC, Dorflinger L, Edmond SN, Islam L, Heapy AA, Fraenkel L. Barriers and facilitators to use of non-pharmacological treatments in chronic pain. BMC Fam Pract. 2017;18(1):41.PubMedPubMedCentral
35.
Neville A, Kopala-Sibley DC, Soltani S, Asmundson GJG, Jordan A, Carleton RN, et al. A longitudinal examination of the interpersonal fear avoidance model of pain: the role of intolerance of uncertainty. Pain. 2021;162(1):152–60.PubMed
36.
Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R, et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci. 2001;21(24):9896–903.PubMedPubMedCentral
37.
Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain. 2000;84(1):65–75.PubMed
38.
Sawamoto N, Honda M, Okada T, Hanakawa T, Kanda M, Fukuyama H, et al. Expectation of pain enhances responses to nonpainful somatosensory stimulation in the anterior cingulate cortex and parietal operculum/posterior insula: an event-related functional magnetic resonance imaging study. J Neurosci. 2000;20(19):7438–45.PubMedPubMedCentral
39.
Kohn A, Chang C. The relationship between Hypermobile Ehlers-Danlos syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and mast cell activation syndrome (MCAS). Clin Rev Allergy Immunol. 2020;58(3):273–97.PubMed
40.
Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017;175(1):8–26.PubMed
41.
Al-Rawi ZS, Al-Aszawi AJ, Al-Chalabi T. Joint mobility among university students in Iraq. Br J Rheumatol. 1985;24(4):326–31.PubMed
42.
Acasuso Diaz M, Collantes Estevez E, Sanchez Guijo P. Joint hyperlaxity and musculoligamentous lesions: study of a population of homogeneous age, sex and physical exertion. Br J Rheumatol. 1993;32(2):120–2.PubMed
43.
Klemp P, Learmonth ID. Hypermobility and injuries in a professional ballet company. Br J Sports Med. 1984;18(3):143–8.PubMedPubMedCentral
44.
Clinch J, Deere K, Sayers A, Palmer S, Riddoch C, Tobias JH, et al. Epidemiology of generalized joint laxity (hypermobility) in fourteen-year-old children from the UK: a population-based evaluation. Arthritis Rheum. 2011;63(9):2819–27.PubMedPubMedCentral
45.
Juul-Kristensen B, Schmedling K, Rombaut L, Lund H, Engelbert RH. Measurement properties of clinical assessment methods for classifying generalized joint hypermobility-A systematic review. Am J Med Genet C Semin Med Genet. 2017;175(1):116–47.PubMed
46.
Smits-Engelsman B, Klerks M, Kirby A. Beighton score: a valid measure for generalized hypermobility in children. J Pediatr. 2011;158(1):119–23. 23 e1-4.PubMed
47.
De Baets S, Vanhalst M, Coussens M, Rombaut L, Malfait F, Van Hove G, et al. The influence of Ehlers-Danlos syndrome - hypermobility type, on motherhood: a phenomenological, hermeneutical study. Res Dev Disabil. 2017;60:135–44.PubMed
48.
Malek S, Reinhold EJ, Pearce GS. The Beighton score as a measure of generalised joint hypermobility. Rheumatol Int. 2021;41(10):1707–16.PubMedPubMedCentral
49.
Singh H, McKay M, Baldwin J, Nicholson L, Chan C, Burns J, et al. Beighton scores and cut-offs across the lifespan: cross-sectional study of an Australian population. Rheumatology (Oxford). 2017;56(11):1857–64.PubMed
50.
Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet. 2017;175(1):148–57.PubMed
51.
Castori M. Ehlers-Danlos syndrome(s) mimicking Child Abuse: is there an impact on clinical practice? Am J Med Genet C Semin Med Genet. 2015;169(4):289–92.PubMed
52.
Barnum R. Problems with diagnosing Conversion Disorder in response to variable and unusual symptoms. Adolesc Health Med Ther. 2014;5:67–71.PubMedPubMedCentral
53.
Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163(20):2433–45.PubMed
54.
Celletti C, Castori M, La Torre G, Camerota F. Evaluation of kinesiophobia and its correlations with pain and fatigue in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type. Biomed Res Int. 2013;2013:580460.PubMedPubMedCentral
55.
Mallorqui-Bague N, Garfinkel SN, Engels M, Eccles JA, Pailhez G, Bulbena A, et al. Neuroimaging and psychophysiological investigation of the link between anxiety, enhanced affective reactivity and interoception in people with joint hypermobility. Front Psychol. 2014;5:1162.PubMedPubMedCentral
56.
Eccles JA, Beacher FD, Gray MA, Jones CL, Minati L, Harrison NA, et al. Brain structure and joint hypermobility: relevance to the expression of psychiatric symptoms. Br J Psychiatry. 2012;200(6):508–9.PubMedPubMedCentral
57.
Bulbena A, Pailhez G, Bulbena-Cabre A, Mallorqui-Bague N, Baeza-Velasco C. Joint hypermobility, anxiety and psychosomatics: two and a half decades of progress toward a new phenotype. Adv Psychosom Med. 2015;34:143–57.PubMed
58.
Kennedy M, Loomba K, Ghani H, Riley B. The psychological burden associated with Ehlers-Danlos syndromes: a systematic review. J Osteopath Med. 2022;122(8):381–92.PubMed
59.
Baeza-Velasco C, Gely-Nargeot MC, Vilarrasa AB, Fenetrier C, Bravo JF. Association between psychopathological factors and joint hypermobility syndrome in a group of undergraduates from a French university. Int J Psychiatry Med. 2011;41(2):187–201.PubMed
60.
Castori M, Morlino S, Celletti C, Ghibellini G, Bruschini M, Grammatico P, et al. Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet A. 2013;161A(12):2989–3004.PubMed
61.
JAMES WII. WHAT IS AN EMOTION ? Mind. 1884;os–IX(34):188–205.
62.
Lange CG. The mechanism of the emotions. The classical psychologists. 1885:672 – 84.
63.
Grahame R. The multisystemic nature and natural history of joint hypermobility syndrome and Ehlers-Danlos syndrome in children: new research data conflict with widely held views. Rheumatology (Oxford). 2017;56(12):2048–9.PubMed
64.
Engelbert RH, Juul-Kristensen B, Pacey V, de Wandele I, Smeenk S, Woinarosky N, et al. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017;175(1):158–67.PubMed
65.
Palmer S, Terry R, Rimes KA, Clark C, Simmonds J, Horwood J. Physiotherapy management of joint hypermobility syndrome–a focus group study of patient and health professional perspectives. Physiotherapy. 2016;102(1):93–102.PubMed
66.
Berglund B, Anne-Cathrine M, Randers I. Dignity not fully upheld when seeking health care: experiences expressed by individuals suffering from Ehlers-Danlos syndrome. Disabil Rehabil. 2010;32(1):1–7.PubMed
67.
Clark DM. A cognitive approach to panic. Behav Res Ther. 1986;24(4):461–70.PubMed
68.
Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci. 1996;351(1346):1413–20.PubMed
69.
Craig AD. Interoception: the sense of the physiological condition of the body. Curr Opin Neurobiol. 2003;13(4):500–5.PubMed
70.
Bulbena A, Duro JC, Porta M, Martin-Santos R, Mateo A, Molina L, et al. Anxiety disorders in the joint hypermobility syndrome. Psychiatry Res. 1993;46(1):59–68.PubMed
71.
Bulbena A, Agulló A, Pailhez G, Martín-Santos R, Porta M, Guitart J, et al. Is joint hypermobility related to anxiety in a nonclinical population also? Psychosomatics. 2004;45(5):432–7.PubMed
72.
Campayo JG, Asso E, Alda M, Andres EM, Sobradiel N. Association between joint hypermobility syndrome and panic disorder: a case–control study. Psychosomatics. 2010;51(1):55–61.
73.
Ercolani M, Galvani M, Franchini C, Baracchini F, Chattat R. Benign joint hypermobility syndrome: psychological features and psychopathological symptoms in a sample pain-free at evaluation1. Percept Mot Skills. 2008;107(1):246–56.PubMed
74.
Lumley MA, Jordan M, Rubenstein R, Tsipouras P, Evans MI. Psychosocial functioning in the Ehlers-Danlos syndrome. Am J Med Genet. 1994;53(2):149–52.PubMed
75.
Pasquini M, Celletti C, Berardelli I, Roselli V, Mastroeni S, Castori M, et al. Unexpected association between joint hypermobility syndrome/Ehlers–Danlos syndrome hypermobility type and obsessive–compulsive personality disorder. Rheumatol Int. 2014;34:631–6.PubMed
76.
Miller AJ, Stiles LE, Sheehan T, Bascom R, Levy HP, Francomano CA, et al. Prevalence of Hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome. Auton Neurosci. 2020;224:102637.PubMedPubMedCentral
77.
Wang E, Ganti T, Vaou E, Hohler A, editors. The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome. Allergy & Asthma Proceedings; 2021.
78.
Fikree A, Chelimsky G, Collins H, Kovacic K, Aziz Q, editors. Gastrointestinal involvement in the Ehlers–Danlos syndromes. American Journal of Medical Genetics Part C: seminars in Medical Genetics. Wiley Online Library; 2017.
79.
Choudhary A, Fikree A, Aziz Q, editors. Overlap between irritable bowel syndrome and hypermobile Ehlers–Danlos syndrome: an unexplored clinical phenotype? American Journal of Medical Genetics Part C: seminars in Medical Genetics. Wiley Online Library; 2021.
80.
Bennett SE, Walsh N, Moss T, Palmer S. The lived experience of Joint Hypermobility and Ehlers-Danlos syndromes: a systematic review and thematic synthesis. Phys Therapy Reviews. 2019;24(1–2):12–28.
81.
Clark CJ, Knight I. A humanisation approach for the management of Joint Hypermobility Syndrome/Ehlers-Danlos syndrome-hypermobility type (JHS/EDS-HT). Int J Qual Stud Health Well-being. 2017;12(1):1371993.PubMedPubMedCentral
82.
Knight I. The role of narrative medicine in the management of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Am J Med Genet C Semin Med Genet. 2015;169 C(1):123–9.PubMed
83.
Terry RH, Palmer ST, Rimes KA, Clark CJ, Simmonds JV, Horwood JP. Living with joint hypermobility syndrome: patient experiences of diagnosis, referral and self-care. Fam Pract. 2015;32(3):354–8.PubMedPubMedCentral
84.
Hugon-Rodin J, Lebegue G, Becourt S, Hamonet C, Gompel A. Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study. Orphanet J Rare Dis. 2016;11(1):124.PubMedPubMedCentral
85.
Bell L, Pearce G. Parents’ experiences of children’s health care for Hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders. Children’s Health Care. 2022;51(1):37–61.
Metadata
Title
A narrative review of the literature on illness uncertainty in hypermobile ehlers-danlos syndrome: implications for research and clinical practice
Authors
Estée C.H. Feldman
Kendra J. Homan
Sara E. Williams
Tracy V. Ting
Kenneth R. Goldschneider
Susmita Kashikar-Zuck
Publication date
16-10-2023
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2023
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-023-00908-6

Other articles of this Issue 1/2023

Screening utility and acceptability of the Kiswahili-pGALS (paediatric Gait, Arms, Legs, Spine) at a tertiary referral hospital in Kenya-A diagnostic accuracy study

  • Open Access
  • Research article

Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study

A systematic review of the psychosocial factors associated with pain in children with juvenile idiopathic arthritis

Profiling the peripheral immune response to ex vivo TNF stimulation in untreated juvenile idiopathic arthritis using single cell RNA sequencing

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity

Treat-to-target strategies for the management of familial Mediterranean Fever in children

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now
Video
Image Credits